New GEP test predicts metastatic risk

Recently released results suggest that a new gene expression profile test is effective for cutaneous melanoma. » Find out more on the test

Share »

Looking to reach your patients in new way?
The right mobile health tool can empower your practice and help utilize clinic time efficiently Click here to request a free demo of Touch Care today.

A-101 achieved statistical significance in clearing SK lesions

Aclaris Therapeutics drug A-101 performed well in clearing multiple seborrheic keratoses (SK) lesions. » Subjects were pleased

Share »

Current and emerging treatments for acne
Learn more about advancing medical therapies that may help clear acne and improve scarring.

Melanoma cells die when denied access to glutamine

Starvation approach might work broadly against many melanoma tumors. » Glutamine addiction

Share »

RECOMMENDED ARTICLES

New Job Opportunities

AZ - Arizona Skin & Laser

CA - Integrated Dermatology

CA - MedDerm Associates

CA - UC Irvine Health Dept Of Dermatology

CT - Integrated Dermatology

CO - Integrated Dermatology

District of Columbia - Integrated Dermatology

FL - Integrated Dermatology

FL - Palm Beach Dermatology

IL - Integrated Dermatology

MI - Fivenson Dermatology PLLC

National - Integrated Dermatology

National - Leavitt Management Group

New Job Opportunities

NC - Integrated Dermatology

NM - Integrated Dermatology

NY - Company Confidential

NY - Juva Skin & Laser Center

OK - Tulsa Cancer Institute

OR - Cynthia Dreyer MD

PA - Dermatology Associates of Lancaster

TX - The University of Texas Health Science Center at San Antonio School of Medicine/Dermatology

UT - Integrated Dermatology

WI - Gundersen Lutheran Health System